Learn moreWe are guided by Our Credo, a set of values that inspires our more than 153,000 employees to put the needs and well-being of the people we serve first. For 80 years, it has motivated us to solve complex health challenges with a spirit of innovation.
Champion global health equity
patients treated globally with a Janssen medicine
cumulative doses of SIRTURO (bedaquiline) treatments for multidrug-resistant tuberculosis shipped
ranking in the 2022 Access to Medicine Index, reflecting our strategy to enable access to our medicines and technologies for people in low- and middle-income countries
nurses, midwives and community health workers supported with skills, tools and growth through the Johnson & Johnson Center for Health Worker Innovation, exceeding the Health for Humanity Goal1
Empower our employees
ethnic/racial diversity in management positions within the U.S., achieving the Health for Humanity 2025 Goal
employees (92%)
responded to Our Credo Survey, with an 87% favorability rate among participants—a testament to our values-driven culture
launched as a dynamic learning and development ecosystem that empowers employees with continuous opportunities for reskilling, upskilling and development
Advance environmental health
renewable electricity secured for our operations in Brazil starting in 2023 through a direct Power Purchase Agreement
for leadership in climate action for the fifth year in a row
(DiCE—Digital Health in a Circular Economy) launched by Janssen, with co-funding from the EU Horizon Europe program, to address digital health waste
Lead with accountability and innovation
invested in research and development across our businesses
updated with expanded expectations on supplier diversity, equity and inclusion, information security and environmental responsibility
employees completed Health Care Compliance training, the highest completion number to date
1 Funded in part by the Johnson & Johnson Foundation, a registered charity and a company limited by guarantee, and by the Corporation and operating companies across the Johnson & Johnson Family of Companies. The Foundation operates worldwide as the Johnson & Johnson Foundation United States (founded 1953) and Johnson & Johnson Foundation Scotland (founded 2007).
Recognitions
ESG Ratings
2 Current ISS ESG score from August 8, 2022 update.
3 The use by Johnson & Johnson of any MSCI ESG Research LLC or its affiliates (“MSCI”) data, and the use of MSCI logos, trademarks, service marks or index names herein, do not constitute a sponsorship, endorsement, recommendation, or promotion of Johnson & Johnson by MSCI. MSCI services and data are the property of MSCI or its information providers, and are provided ‘as-is’ and without warranty. MSCI names and logos are trademarks or service marks of MSCI.
